RecruitingNCT05934149

Lupus Landmark Study: A Prospective Registry and Biorepository

Lupus Nexus Landmark Study: A Prospective Registry and Biorepository


Sponsor

Lupus Research Alliance

Enrollment

3,500 participants

Start Date

Jun 28, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).


Eligibility

Min Age: 18 YearsMax Age: 110 Years

Inclusion Criteria4

  • Able to understand and comply with study procedures and voluntarily sign a written informed consent document
  • Age 18 years or older at the time of enrollment
  • Fulfill criteria for SLE based on one or more of the following classifications systems:
  • Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.

Exclusion Criteria3

  • Not able to obtain consent
  • Not able to meet protocol visit requirements
  • Pregnant at the time of enrollment

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(25)

University of Alabama at Birmingham

Birmingham, Alabama, United States

University of Arizona

Tucson, Arizona, United States

Wallace Rheumatic Studies Center

Beverly Hills, California, United States

UCLA

Los Angeles, California, United States

Georgetown University

Washington D.C., District of Columbia, United States

University of Miami

Miami, Florida, United States

Emory University

Atlanta, Georgia, United States

University of Chicago

Chicago, Illinois, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

University of Massachusetts Memorial Health

Worcester, Massachusetts, United States

Washington University

St Louis, Missouri, United States

The Feinstein Institutes for Medical Research

Manhasset, New York, United States

Columbia University Medical Center

New York, New York, United States

Northwell Health

New York, New York, United States

SUNY Upstate

Syracuse, New York, United States

UNC Chapel Hill

Chapel Hill, North Carolina, United States

The MetroHealth System

Cleveland, Ohio, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

UT Southwestern Medical Center

Dallas, Texas, United States

University of Calgary

Calgary, Alberta, Canada

University of Alberta Hospital

Edmonton, Alberta, Canada

University of Manitoba

Winnipeg, Manitoba, Canada

University Health Network/Toronto Western Hospital

Toronto, Ontario, Canada

McGill University Health Centre

Montreal, Quebec, Canada

CHU de Québec - Université Laval

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05934149


Related Trials